ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $26,585 | +27.3% | 1,110 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $20,890 | +18.2% | 1,110 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $17,671 | +10.4% | 1,110 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $16,000 | 0.0% | 1,110 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $16,000 | -57.9% | 1,110 | -31.1% | 0.00% | -50.0% |
Q4 2021 | $38,000 | +26.7% | 1,610 | -11.0% | 0.00% | +100.0% |
Q3 2021 | $30,000 | -42.3% | 1,810 | -14.8% | 0.00% | -50.0% |
Q2 2021 | $52,000 | +1633.3% | 2,125 | +2025.0% | 0.00% | – |
Q1 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |